JAMES J. FALLON,JAMES SZIGETHY,JOAN M. FALLON,KENNETH NANUS,MATTHEW F. HEIL
申请号：
BR112014016557
公开号：
BR112014016557A8
申请日:
2013.01.03
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract of the disclosure [0001] disclosed are methods of using coated digestive enzyme preparations and enzyme delivery systems and pharmaceutical compositions comprising the preparations for treatment of subjects having behavioral disorders, neurological disorders or mental health disorders. disclosed herein are methods of treating core and non-core symptoms of behavioral disorders, neurological disorders or mental health disorders. Also disclosed herein are products for use in methods of treatment and methods of making the same. ************************* Summary of the Patent Summary: "Methods of treating behavioral symptoms of neurological and mental disorders". The present invention relates to methods of using coated digestive enzyme preparations and enzyme delivery systems and pharmaceutical compositions comprising preparations for treating individuals having behavioral disorders, neurological disorders or mental health disorders. Methods of treating core and non-core symptoms of behavioral disorders, neurological disorders or mental health disorders are disclosed herein. Also disclosed herein are products for use in treatment methods and methods of manufacturing them. more specifically, the present application discloses methods of treating an individual with symptoms of an autistic spectrum disorder (asd) comprising compositions comprising pancreatic digestive enzymes such as pancreatin, lipase, amylase and protease. wsgr docket no. 41012-727601 2- 21712855v1abstract of the disclosure [0001] disclosed herein are methods of using coated digestive enzyme preparations and enzyme delivery systems and pharmaceutical compositions comprising the preparations for treatment of subjects having behavioral disorders, neurological disorders or mental health disorders. disclosed herein are methods of treating core and non-core symptoms of behavioral disorders, neurological disorders or mental health disorders. also disclosed herein are products for use in methods of treat
